Perrin Steven's Form 4 filing
Eledon Pharmaceuticals, Inc. (ELDN) · filed Nov 23, 2022
- Accession no.
- 0001209191-22-058608
- Filed
- Nov 23, 2022
- Trade date
- Nov 23, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.60K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Perrin StevenCIK 0001824545 | Director, Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $2.60 | +$2,600 | 1,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.